271 related articles for article (PubMed ID: 19526965)
1. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
2. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
Jenh AM; Pham PA
Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1079-92. PubMed ID: 20954872
[TBL] [Abstract][Full Text] [Related]
3. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
4. [Chronic hepatitis B. Tenofovir--the right choice from the beginning].
MMW Fortschr Med; 2008 May; 150(21):42-3. PubMed ID: 18575255
[No Abstract] [Full Text] [Related]
5. Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
Prescrire Int; 2009 Jun; 18(101):116. PubMed ID: 19637428
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.
Liu Y; Wang CM; Cheng J; Liang ZL; Zhong YW; Ren XQ; Xu ZH; Zoulim F; Xu DP
Chin Med J (Engl); 2009 Jul; 122(13):1585-6. PubMed ID: 19719953
[No Abstract] [Full Text] [Related]
7. Europe extends Viread indication for chronic hepatitis B.
AIDS Patient Care STDS; 2008 Apr; 22(4):350. PubMed ID: 18434949
[No Abstract] [Full Text] [Related]
8. Tenofovir for the treatment of hepatitis B virus.
Jenh AM; Thio CL; Pham PA
Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
[TBL] [Abstract][Full Text] [Related]
9. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
Bronowicki JP; Barraud H; Couzigou P
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
[No Abstract] [Full Text] [Related]
10. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.
Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V
Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064
[No Abstract] [Full Text] [Related]
11. Tenofovir salvage for nucleoside experienced patients: muddy waters?
Mutimer D
Gut; 2011 Feb; 60(2):148-50. PubMed ID: 21205876
[No Abstract] [Full Text] [Related]
12. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Van Bömmel F; Schernick A; Hopf U; Berg T
Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
[No Abstract] [Full Text] [Related]
14. Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop.
Carosi G; Rizzetto M; Alberti A; Cariti G; Colombo M; Craxì A; Filice G; Levrero M; Mazzotta F; Pastore G; Piccinino F; Prati D; Raimondo G; Sagnelli E; Toti M; Brunetto M; Bruno R; Di Marco V; Ferrari C; Gaeta GB; Lampertico P; Marzano A; Pollicino T; Puoti M; Santantonio T; Smedile A
Dig Liver Dis; 2011 Apr; 43(4):259-65. PubMed ID: 21276760
[TBL] [Abstract][Full Text] [Related]
15. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
Isakov VA
Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
[No Abstract] [Full Text] [Related]
16. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
Hilgendorf I; Loebermann M; Borchert K; Junghanss C; Freund M; Schmitt M
Bone Marrow Transplant; 2011 Sep; 46(9):1274-5. PubMed ID: 21151183
[No Abstract] [Full Text] [Related]
17. Chronic hepatitis B: who to treat and which choice of treatment?
Di Marco V; Craxì A
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B: update 2009.
Lok AS; McMahon BJ
Hepatology; 2009 Sep; 50(3):661-2. PubMed ID: 19714720
[No Abstract] [Full Text] [Related]
19. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Marcellin P; Lada O
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
[No Abstract] [Full Text] [Related]
20. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Bourlière M
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
